Leadership Overview
STAAR Surgical has 4 executives leading key functions including corporate strategy, financial oversight, and operational management.
Focused on advancing vision correction technology, STAAR Surgical delivers innovative implantable lenses and delivery systems to global markets while maintaining a commitment to superior patient outcomes and long-term clinical excellence.
Focused on advancing vision correction technology, STAAR Surgical delivers innovative implantable lenses and delivery systems to global markets while maintaining a commitment to superior patient outcomes and long-term clinical excellence.
Leadership Roles at STAAR Surgical
David Bailey - President & Chief Executive Officer
David Bailey, the President & Chief Executive Officer at STAAR Surgical, directs the overarching corporate strategy for the development and manufacturing of implantable lenses. Bailey manages the expansion of market reach across international territories, ensuring that the company maintains a competitive edge in the medical device sector. By aligning research initiatives with commercial goals, the President & Chief Executive Officer drives sustainable growth and innovation in vision correction technology. This leadership role involves constant collaboration with the board to refine long-term objectives and operational efficiency. David Bailey monitors global market trends to anticipate shifts in demand for advanced ocular delivery systems. Through rigorous oversight of organizational performance, the President & Chief Executive Officer secures the financial health of the enterprise. Ultimately, Bailey fosters a culture of excellence that supports the delivery of high-quality surgical solutions to patients worldwide.
Barry Caldwell - President & Chief Executive Officer
Barry Caldwell, the President & Chief Executive Officer at STAAR Surgical, architects the operational framework for manufacturing high-precision implantable lenses. Caldwell focuses on optimizing supply chain logistics and production capacity to meet the rising global demand for vision correction products. The President & Chief Executive Officer oversees the integration of new manufacturing technologies to enhance product reliability and safety standards. By streamlining internal processes, Barry Caldwell ensures that the company achieves maximum output efficiency while adhering to strict regulatory requirements. This leadership role requires constant coordination with engineering teams to refine delivery systems and improve surgical outcomes. Through the implementation of scalable production strategies, the President & Chief Executive Officer supports the company's mission to provide life-changing ocular solutions. Caldwell maintains a sharp focus on operational excellence to sustain the competitive position of the organization within the medical device industry.
Marie Becker - Chief Financial Officer
Marie Becker, the Chief Financial Officer at STAAR Surgical, manages the fiscal health and capital allocation strategies for the organization. Becker oversees financial planning, reporting, and investor relations to ensure transparency and long-term value creation. The Chief Financial Officer directs the budgeting process, providing the necessary resources for research and development of advanced implantable lenses. By analyzing market data and operational costs, Marie Becker identifies opportunities for margin improvement and revenue growth. This leadership role involves close coordination with executive peers to align financial goals with the broader corporate mission. Through the management of global financial risks, the Chief Financial Officer protects the assets of the company while supporting expansion into new geographic markets. Becker maintains rigorous internal controls to ensure compliance and operational integrity. Ultimately, the Chief Financial Officer provides the financial stability required to advance the company's innovative vision correction portfolio.
Sara Stickfug - President
Sara Stickfug, the President at STAAR Surgical, leads the commercialization efforts and market penetration strategies for the company's suite of implantable lenses. Stickfug oversees the execution of sales initiatives and marketing campaigns designed to increase adoption among ophthalmic surgeons. The President drives the development of strategic partnerships to expand the footprint of the company in key international regions. By analyzing clinical feedback and patient needs, Sara Stickfug ensures that the product portfolio remains at the forefront of vision correction technology. This leadership role involves managing cross-functional teams to deliver comprehensive support and training for the company's delivery systems. Through the implementation of targeted growth strategies, the President enhances the market presence and brand recognition of the organization. Stickfug maintains a focus on customer engagement to drive sustained revenue growth and clinical success. Ultimately, the President ensures that the company delivers superior value to both surgeons and patients.
Explore Leadership Teams in Manufacturing
B. Braun Melsungen AG is a German multinational medical devices and pharmaceutical company headquartered in Melsungen, Hesse. Founded in 1839, the company develops, manufactures, and markets a broad range of medical products and services including infusion therapy, surgical instruments, wound care, dialysis, and hospital pharmacy solutions. B. Braun operates in over 60 countries worldwide.
Company Leadership MD
FF
SE
Headquartered in Glen Allen, Virginia, Owens & Minor is a distributor of national name-brand medical and surgical supplies and a healthcare supply-chain management company. With a diverse product and service offering and distribution centers throughout the United States. The company serves hospitals, integrated healthcare systems, alternate care locations, group purchasing organizations, and the federal government. Owens & Minor provides technology and consulting programs that improve inventory management and streamline logistics across the entire medical supply chain--from origin of product to patient bedside.
Company Leadership DM

CC

Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. The company's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally. The company's systems support treatment of various cancer types across different anatomical sites, from brain and head-and-neck tumors to thoracic and abdominal malignancies. Healthcare providers rely on Accuray's technology to expand their treatment capabilities and improve clinical outcomes for patients who might otherwise have limited options.
Company Leadership

KT
As per the "buy and build" strategy, the next acquisition was Legacy Medical (July 2018), followed by Haemotec (Nov 2019) and LTE Medical Supplies (Feb 2019). In April 2019, the company started an Ophthalmology business (EyeCare) and have expanded the company's product range and agencies in the existing verticals. The second half of 2019 saw further acquisitions with Paragmed in November and Jumla Medical Supplies and Stratmed joining the group in December. The company is a scaled and diversified group of specialised medical service providers committed to bringing new, first-rate technologies to a wide spectrum of medical practitioners. The company provides the latest devices, software, processes and procedures that facilitate high care and quality treatment for all patients. The company's clients and partners continually receive extensive training and comprehensive technical support as the company strives towards better products, better services and more personalised customer experiences. Depiction of Vertice MedTech
Company Leadership HP
GS
BM
EM